HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy (Q81276843)
Jump to navigation
Jump to search
scientific article published on 01 June 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy |
scientific article published on 01 June 2008 |
Statements
HER-2/neu assessment in breast cancer using the original FDA and new ASCO/CAP guideline recommendations: impact on selecting patients for herceptin therapy (English)
Matteo Brunelli
Guido Martignoni
Samantha Bersani
Daniela Reghellin
Marco Chilosi
Franco Bonetti